A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advanced Hepatocellular Carcinoma.
- Roberts, Stuart (Primary Chief Investigator (PCI))
- Lewis, Paula (Project Manager)
- George, Jacob (Chief Investigator (CI))
- Zekry, Amany (Chief Investigator (CI))
- O'Beirne, James (Chief Investigator (CI))
- Tse, Edmund (Chief Investigator (CI))
- McLachlan, Sue-Anne (Chief Investigator (CI))
- Eastgate, Melissa (Chief Investigator (CI))
- Ananda, Sumitra S (Chief Investigator (CI))
- Davison, Scott (Chief Investigator (CI))
Project: Research